Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dr. Blumhoff effectively owns CGHC in a shrewd reverse takeover. His was a private group of urgent healthcare clinics that got bought over with a promise that could not be kept by the former executives.
It was therefore obvious CGHC fell into his control without having to spend money to buy over CGHC. The departed exectives got hardly anything.
Now it is to build value into CGHC, to look into business expansion and to get deep-pocket investors.
Playing games with share price dilution will not help Dr. Blumhoff. The old agreement can be cancelled anytime as the company now belongs to him.
I will accumulate.
Perhaps there is a theory called Momentum of Time.
With time, AMBS continues to refine their research, develop more business strategies and fortify their business plans.
They are not static. They appear in scientific conferences and the Internet can be brutal if they present data that do not stand up to scrutiny.
With the momentum of time, AMBS has a a higher chance of a big upside than a big decline.
This became a shrewd reverse takeover with almost all the shares going to Mike Blumhoff. He did not need to spend millions to buy control of CGHC. And there was not even a goodwill extended.
There is no dilution to shareholders as Mike will only be diluting his own valuation now that he is the majority share-holder.
OHUC continues to be profitable and I presume their next target will be to get additional financing, expand and even look at new targets.
The expensive overheads have come down significantly which means the profits will go up. The payoffs to the departing directors was surprisingly very low.
We all speculate as to what is happening and may happen.
Dr. Rubinfeld is an advisor and hence is not likely to paid much as AMBS is not earning revenue.
He may be the banker of last resort and may be advisor others on financing AMBS while the big deal is being lined up and he is then heavily involved.
That we some eminent advisors in AMBS gives me lots of confidence in the future.
I am selling other OTC counters are no profits or even minor losses and buying CGHC:
- The CEO has a track record and will work to get his financial support now that the old team is gone.
- No more gimmicks on PPS guarantee and working out how to pay off the acquisition.
- There are more potential in that business.
For AMBS to get financing at 8% p.a. is really cheap for a development stage company.
I lend to biotech firms too but at 15% and in one instance at 30%. And I have security over certain assets / software technology.
So it is credit to AMBS that they could get Dominion to lend them money at such low rates.
It shows that Dominion knows the value of AMBS and they have a ultra-low conversion value at 0.03 for common stock.
I do not understand the rationale for "complete loss" for common shareholders. This is a complete write-off only if AMBS goes bankrupt.
Dominion or any deep pocket investor can take over and grow it. They the scientists and the reseasrch. It is foolish to buy a company just to close it down.
Anyone who is invested substantially with AMBS has a stake in keeping it alive so that their investment survives and grows.
Looks you have not read their 10Q. They secured funding for over 1 million USD in exchange for shares.
Their expenses are not much different from previous quarters for the intensity of research they are doing.
What would you expect of a development stage company with no revenue? They have to develop in order to earn mega revenue.
I wonder why anyone bothers with development stage companies if they do not understand the economics.
CGHC has a bright future ahead. It is now fully under the control of Dr. Blumhoff who is an expert in urgent care and who has a successful track record in growing this business.
It also has a director in Mr. Guillama, someone whom I know well and who is a very capable person running his own emerging enterprise.
It also looks like the whole deal has gone terribly wrong for previous directors of CGHC. It is now a reverse takeover by Dr. Blumhoff and he got the entire CGHC.
I will accumulate in anticipation that Dr. Blumhoff and Mr. Guillama will now make this a truly successful business.
GLTA
There is more than a fair chance...depends on Molen to a large extent. He knows what I am talking about if he reads this blog.
Hi Tedlar Paper, I am not much of a drinker but I will accept the free beer when that day comes. Thanks
Have pvt message you. Cheers.
Dr. Rubinfeld is already a multi-hundred millionaire. He can easily bankroll AMBS to success. You do not become a co-Founder of Amgen and remains a wage earner only.
Very exciting times indeed, in the next several weeks I think it could possibly drop big time or hit a $1 or higher like you said. Lets hope for the latter. I think people like Dr. Rubenfeld have better things to do than be part of a penny stock scam.
Getting delisted and going private does not extinguish the right of existing shareholders.
I am investing in an upcoming exciting medical informatics firm that went private in the aftermath of the 2008 Financial Crises.
The CEO told me there are still 2000 shareholders from the legacy listed firm and they have their entitlements still. He went private but not go bankrupt.
And this firm is heading back to be a billion-dollar play. I should know as I am intimately involved with their resurrection.
I share your view.
The other option is that LymPro is licensed by Becton Dickinson and the share price moves above $1.00 and then Amgen enters into a license agreement to develop MANF and the share price moves over $5.00.
This doesn't happen to thousands of companies but it may well happen to "$AMBS".
I am glad Whitman escaped more serious injuries. He is probably more aware of the karma that comes with doing good and vice versa.
He is a grandfather too and should look forward to many happy years ahead. As CEO his fiduciary duty is to protect shareholders interests.
BTHR has declined to the graveyard at 0001. If Whitman has been manipulating this counter with schemes designed to defraud the investors, he should be well aware that there are bigger forces at play.
The Chinese say a small mishap prevents a bigger mishap. It is also a warning to Whitman.
In this news it was quoted: I hope to see that announcement soon.
The Company expects to hire several key employees early next week and have leases signed on the first two locations by Wednesday, August 7, 2013. Announcements will also be forthcoming on the type of restaurant brand the Company is planning to open.
If we go by statistics, then Nike, Facebook, Google, etc. should not be around. Most start-ups fail. Therefore their creators would have been so discouraged, they would have looked for jobs instead.
For me I go by intuition and not by statistics. I like what AMBS is doing and I hope they succeed. I will bet on their mega success.
Some say they will need many millions for clinical trials. Maybe and maybe not. Their latest announcement about potential orphan status for Lympro has not got the crowd really excited. Good for the intuitive investor...he sees a rainbow beyond the dark clouds.
But go back to last year when the price at at 0.03 level without these hopeful news. The crowd was buying too.
For me, my investment intuition has made me lots of money (and I lost some too). I will stick to that.
I think this is very good news. CGHC is back in the hands of a dedicated professional and can concentrate on growth and investor interests.
I look forward to PPS going up now.
And all those agreements on floor price and compensation are now null and void. I was wondering how CGHC could ever uphold that agreement on compensation.
I had speculated in an earlier post the company will be handed over to the original seller.
Interesting argument.
MANF is not a drug created in the pharma lab. And it is not one of thousands of biologics that under pre-clinical screening. So that 5000:1 may not apply.
MANF has been the protein that Gerald's father has been studying for over ten years if I am not mistaken.
We can use statistics to argue on both sides of the coin.
I will paste some quotes from Dr. Jerry. He has not appeared here for a while:
Quote: CED (convection enhanced delivery) and new micro catheters that are placed stereotactically will revolutionize the development and commercialization of MANF
Quote: Gerald has gathered a team of experts in their respective fields of medicine, chemistry and marketing. These big names are not here for pennies
Quote: I have a very close friend who is an executive at BioReference Labs Inc in New Jersey. We talked about the addition of Dr. Adam Simon to the Advisory Board of AMBS and he knows of his work in the area of Alzheimer's Disease and his quest for the biomarkers of this horrible disease that has gone without any recent advances in diagnosis or treatment in the last 30 years.
From what he told me from previous experiences, they usually bring on a person about 6 months prior to the commercialization of a new test and he believes that LymPro will be a huge success and first in class.
Milestones have been met in the trial and this is what has attracted the rare talent of late. This is a signal of positive developments in the clinical trial of LymPro
Please provide links to scientific papers that support your argument.
"The end is near" Hear ye, Hear ye.
That was July 18. Now it is close to Aug 18. Perhaps the "end" will occur on Dec 18, if ever.
In 2007 there was press write-up on that Sanswire scam. And Molen has survived the last six years as a free bird.
He has survival tactics that outlasts many critics.
I am not a fan of Molen nor I treat him as my idol. Just challenging the historians here. History has not ruined him. What else will?
This issue was reported in 2007, almost six years ago. Molen has not been prosecuted by the federal authorities. Reporters and laymen can claim it is fraud. So why no prosecution then?
The Courts have not pronounced judgement nor jailed him. In fact he was not even charged in Court.
Smart idea? Definitely. Investor Fools? Possibly.
Torrefaction is not a proprietary technology owned by Molen. It is all there in Google and even names of companies and researchers are known.
VGPR is just like any jackpot...pull the handle and gold coins may actually come out. It may also be a jackpot.
Lay is all out...all the scams that Molen is alleged to have perpetrated.
Either FBI and the Justice Department are too busy or short-handed, Molen is still around today.
Why? He must be a Houdini then.
I was in discussion with the CEO of an Australian firm dealing with a certain body protein that will target lung diseases. Because the same protein is involved with other essential immune responses, I asked whether the drug will diffuse to other parts of the body and he said they already know the cellular mechanism.
I am sure AMBS scientists have mapped out MANF and whatever they are doing. Research is not just at AMBS alone and there are plenty going in various universities. These days with massive computing power they can even simulate cellular functions without having to so do much physical laboratory work.
They call it alogrithms. Harnessing the computer in scientific research is now so routine that even the smallest laboratory does it.
I should know. My brother-in-law over in Vienna is using the computer to sieve through billions of cancer-treatment proteins to find the right biologic candidates for testing.
AMBS is a good counter to make money so long as one is not greedy.
It is quite predictable. This is a very attractive level. And for those with funds it is a good play.
However if it drops to the 02s, then I start another basket and collect them too.
And I will do that if it ever revisit the 01s. I recall I started at 0.012 last Dec.
And with each passing month they make further progress. Will it cost tens of millions? This is not a new pharma drug. Toxicology tests are not going to be that expensive to carry out. This is a body protein not a chemical concoction.
Animal tests are always used in pre-clinicals and options are vetted at that stage. The FDA does have strict rules but they are not so demanding as to fail most candidates.
Their ability to get orphan status is a tremendous break-through.
That is a good tactic.
In capital projects (where I have 30 years with the biggest oil and gas company), we call it risk assessment. AMBS is much de-risked today versus a year ago.
Those who are easily disappointed and selling off too quickly i.e. down from 0.04 plus to 0.03 levels are just putting shares in the hands of punters like me. We know it will float back up to 0.04 and may float down again....it is the yo-yo that makes good steak dinner money.
And then one day it will just go up and never re-visit this level again. So I have some shares parked aside for that ride to the moon.
Naked shorts will be severely burnt if they try their game now. AMBS has certified technology, is going in for clinical trials, are backed by solid talent and also has eminent advisors. Tell me which company has such a combination?
Need for funding? You bet. It is easy for them to raise 10 MUSD now and we do not kwow who they are talking to.
Cheers.
UCC also has X-rays, blood tests, heart beat measurements, etc. They are also small surgeries. So it is not just a General Practitioner and hence it is not a physician clinic.
I have been to one and thankfully it was covered by my work insurance. Cost me almost $200 for a short consultation as I was worried about an incessant cough that did not clear up after a flu.
Now how many patients are required to make a daily profit with that kind of costs? And $200 is really a small sum these days if one reads articles on the very high cost of medical care.
The markup on medication is very high. A UCC is just a small medical centre.
Yes I look forward to 02s and even 01s (that was where I first entered).
Now that AMBS is further down the road, it will just mean a bonanza later. Those who are not invovled with scientific or engineering research just do not appreciate the process.
Funding is never an issue for AMBS now that they are moving ahead with Lympro.
An Australian company, Regeneus, has just entered ASX with an IPO to raise 12 million A$ and they are likely to succeed. Into operations with low EBIDTA, just one product line and not even in the mega industry that AMBS is in.
Gerald cannot create magic with a wand. It is years of hard slog and patience. But big investors (and that includes me) are watching and waiting.
I am making some money (in the low hundreds) by trading AMBS between 0.03 to 0.044 roughly.
Investors are myopic. They want the Alladin's cave to be unlocked and the riches to pour out. No matter what AMBS says, they want the diamonds now.
The naked shorts have been burnt along with their conniving broking houses. Serves them right.
I am waiting to accumulate as AMBS goes back down to around 0.03.
I do not have large positions but am keeping some for the long term where I think AMBS will be really a high PPS.
AMBS is a genuine stock and I respect the hard work being put in by the scientists. I hope they succeed as that will help so many patients.
Nice to get this understanding of the DTC chill.
I deal only through ETrade and finds them highly reputable...no shares, no selling. No cash, no buying either. And they do not accept pennystocks transferred in from anyone else.
That is wonderful. So it is not possible for ETrade to have naked shorts on pennystocks.
One other reputable practice what rejection of my fund transfers from a Joint account when my ETrade was in my name only. I sorted that out by making my ETrade account a joint account (with my spouse). I really respect ETrade for their integrity.
It is a scandal when market markers in connivance with broking houses particpate in naked shorts.
And I respect Gerald for fighting this battle to punish them.
With the high medical charges in USA, Urgent Care Centres can be a money spinner.
Patients go there when they get worried and want a diagnosis and a doctor's opinion. If they are really that serious, then UCC will refer them to a hospital for admission.
And if is the usual range of symptoms (high fever, pain, etc.), then the precriptions may not be that elaborate. UCC are not primary physicians for long term follow-up. And the waiting time is perhaps much shorter than going to the ER of a large hospital.
As they are not hospitals, they do not have the high overheads.
It has been many months since my phone conversation with Ed Withrow. He had spoken about a Stage I and II trials.
It also costs money per patient and so expanding that to 1,000 can cost him several millions USD.
40 patients is a good start.
Obviously ESSI needs to move faster as competitors will be launching their products too.
Many pennystocks CEOs must be worried.
http://au.finance.yahoo.com/news/suspects-face-arraignment-global-penny-104233274.html
The above news clearly shows that the USA government takes actions against fraud via pump and dump.
Many pennystocks CEOs must be worried.
http://au.finance.yahoo.com/news/suspects-face-arraignment-global-penny-104233274.html
The above news clearly shows that the USA government takes actions against fraud via pump and dump.
CCAJ has never dropped below 0.0003 and I keep wondering why.
Some other OTCs have gone to 0001 and are staying there. Someone is supporting CCAJ at 3 and 4 all these months.
There is a plan somewhere. And that means it can go back up once the plan is announced.
Read this....
Stock Price Guarantee for Year #1, if by September 5, 2013, the Closing Price of the common stock of Capital Group Holdings, Inc. has not been equal to or exceeding $1.00 for 20 consecutive trading days immediately prior, Capital Group Holdings, Inc. shall issue to Sellers such number of additional restricted shares of its common stock as to make up the difference between $10,000,000 (10,000,000 purchase shares X $1.00) and the actual Closing Price of the common stock multiplied by 10,000,000 shares. (For example if the actual Closing Price of the common stock was $.80, Sellers would be issued 2,500,000 additional shares. {$10 million – $8 million [$0.80 X 10,000,000 = $8,000,000] = $2 million shortfall; $2,000,000/$0.80 per share = 2,500,000 shares).
They are now in an interesting situation. Come Sept 5, they will have to virtually hand over the company to the MCS Ventures, the Sellers.
There can be no stock dilution. And they guaranteed to make up the difference between today's ultra low PPS of 0.02 and $1.00 i.e. $0.98 and not the 20 cents difference in the paragraph above.
There is no way they CAN make it to $1.00 and maintain that for 20 consecutive trading days. It will mean CGHC is given away free back to MCS Ventures. Or a miracle may happen.
Pictures are available from Molen. I got a few and anyone can also ask him for them.
And per Molen, the pilot plant is still there. Ask him.
You are speculating about the dumping. Have you any proof?
Dumping by whom? By Molen?
Tony's business has not gone bankrupt. I presume his beautiful tiles are still selling and that he has more projects.
That CCAJ has not been delisted means there are plans. Just need to wait.
Fully support AMBS. Those impatient should buy APPLE, the first stock that appears on iHub list. Those who likes the Journey of Faith, can stay with AMBS.
I invest for the long term when the PPS is so low as it is now.
Rubbish to say a toxic financier owning just 7% of AMBS is running the company. Pure rubbish.